VVOS Vivos Therapeutics, Inc.

NASDAQ
$0.06

Vivos Therapeutics, Inc. (VVOS) Earnings News

Earnings press releases, previews and reviews for Vivos Therapeutics, Inc. (VVOS), newest first. Our most recent is review: Vivos Therapeutics Beats Estimates, but a One-Time Credit and a $247,000 Cash Balance Overshadow the Quarter.